SecBot SecBot

LYCA

Lycia Therapeutics, Inc.
Nasdaq· CIK 0001806540 Biotech & Drug Discovery
$28.85 −1.15 (−3.83%)
Oct 26 4:00 PM ET · prev $30.00
Insider net
$0
no open-market trades · 12 mo
Filing reports
2
analyzed by SecBot
SecBot read BULLISH 3 reports · 90 days
Balance 0 bearish · 1 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/3
Strongest BULLISH Lycia Therapeutics' IPO registration (S-1, File No. 333-299300) became effective on October 22, 2026. The…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 Press
🔒 Fresh report (last 24h), subscribers only
Oct 26, 2026 Offering
🔒 Fresh data, subscribers only
Oct 23, 2026 SEC
Lycia Therapeutics priced its IPO at $18.00 per share, selling 17,640,000 shares for total gross proceeds of $317.5…
424B4 — Impact 5/10
Oct 23, 2026 SEC
Lycia Therapeutics' IPO registration (S-1, File No. 333-299300) became effective on October 22, 2026. The company is…
EFFECT — Impact 7/10
Oct 22, 2026 Insider
🔒 Fresh data, subscribers only
Oct 22, 2026 Insider
🔒 Fresh data, subscribers only
Oct 22, 2026 Insider
🔒 Fresh data, subscribers only

Insider ledger

Form 4
🔒 Subscribers only
11 transactions
DateInsiderTypeValue
Oct 22, 2026🔒 Fresh data, subscribers onlyAWARD
Oct 22, 2026🔒 Fresh data, subscribers onlyAWARD
Oct 22, 2026🔒 Fresh data, subscribers onlyAWARD
Aug 11, 2026🔒 Fresh data, subscribers onlyAWARD
Aug 11, 2026🔒 Fresh data, subscribers onlyAWARD
Aug 11, 2026🔒 Fresh data, subscribers onlyAWARD
Aug 11, 2026🔒 Fresh data, subscribers onlyAWARD
Aug 11, 2026🔒 Fresh data, subscribers onlyAWARD

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 26, 2026
Offering
🔒 Fresh data, subscribers only
Oct 23, 2026
Listing
New Listing: LYCA — Lycia Therapeutics, Inc. - Common Stock
Listed on exchange Q

SecBot reports

2 filings · 1 press release · 1 bullish · 0 bearish · 1 neutral
All LYCA filing & press-release reports (3)